Nauras Shuker

969 total citations
16 papers, 734 citations indexed

About

Nauras Shuker is a scholar working on Transplantation, Pediatrics, Perinatology and Child Health and Surgery. According to data from OpenAlex, Nauras Shuker has authored 16 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Transplantation, 12 papers in Pediatrics, Perinatology and Child Health and 7 papers in Surgery. Recurrent topics in Nauras Shuker's work include Renal Transplantation Outcomes and Treatments (16 papers), Pharmacological Effects and Toxicity Studies (12 papers) and Organ Transplantation Techniques and Outcomes (6 papers). Nauras Shuker is often cited by papers focused on Renal Transplantation Outcomes and Treatments (16 papers), Pharmacological Effects and Toxicity Studies (12 papers) and Organ Transplantation Techniques and Outcomes (6 papers). Nauras Shuker collaborates with scholars based in Netherlands, China and United States. Nauras Shuker's co-authors include Dennis A. Hesselink, Teun van Gelder, Rachida Bouamar, Willem Weimar, Ron H. N. van Schaik, Joke I. Roodnat, Corrado Bernasconi, Henrik Ekberg, Bruce Kaplan and Carla C. Baan and has published in prestigious journals such as Transplantation, American Journal of Transplantation and Clinica Chimica Acta.

In The Last Decade

Nauras Shuker

16 papers receiving 728 citations

Peers

Countries citing papers authored by Nauras Shuker

Since Specialization

Citations

This map shows the geographic impact of Nauras Shuker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nauras Shuker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nauras Shuker more than expected).

Fields of papers citing papers by Nauras Shuker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nauras Shuker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nauras Shuker. The network helps show where Nauras Shuker may publish in the future.

Co-authorship network of co-authors of Nauras Shuker

This figure shows the co-authorship network connecting the top 25 collaborators of Nauras Shuker. A scholar is included among the top collaborators of Nauras Shuker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nauras Shuker. Nauras Shuker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Conversion from tacrolimus to everolimus with complete and early glucocorticoid withdrawal after kidney transplantation: a randomised trial. 2018 ·PubMed ·Rachida Bouamar, Nauras Shuker, J. Osinga, Marian C. Clahsen‐van Groningen, Jeffrey Damman, Carla C. Baan, Jacqueline van de Wetering, Ajda T. Rowshani, (unknown), W. Weimar, Teun van Gelder, Dennis A. Hesselink	6
2	Highly sensitive and rapid determination of tacrolimus in peripheral blood mononuclear cells by liquid chromatography–tandem mass spectrometry 2018 ·Biomedical Chromatography ·Soma Bahmany, L. Elly A. de Wit, Dennis A. Hesselink, Teun van Gelder, Nauras Shuker, Carla C. Baan, Bart C.H. van der Nagel, Birgit C. P. Koch, Brenda C. M. de Winter	27
3	CYP3A5 and ABCB1 Polymorphisms in Living Donors Do Not Impact Clinical Outcome After Kidney Transplantation 2018 ·Pharmacogenomics ·Lin Yang, Brenda C. M. de Winter, Ron HN van Schaik, (unknown), (unknown), Louise M. Andrews, Nauras Shuker, Soma Bahmany, Birgit C. P. Koch, Teun van Gelder, Dennis A. Hesselink	8
4	Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Starting Dose 2017 ·Transplantation Direct ·Louise M. Andrews, Brenda C. M. de Winter, Jiangtao Tang, Nauras Shuker, Rachida Bouamar, Ron H. N. van Schaik, Birgit C. P. Koch, Teun van Gelder, Dennis A. Hesselink	28
5	Intrapatient Variability in Tacrolimus Exposure Does Not Predict The Development of Cardiac Allograft Vasculopathy After Heart Transplant. 2017 ·Experimental and Clinical Transplantation ·Nauras Shuker, Rachida Bouamar, Dennis A. Hesselink, Teun van Gelder, Kadir Çalişkan, Olivier C. Manintveld, Aggie H.M.M. Balk, Alina A. Constantinescu	12
6	A high intrapatient variability in tacrolimus exposure is associated with poor long-term outcome of kidney transplantation 2016 ·Transplant International ·Nauras Shuker, (unknown), Joost van Rosmalen, Joke I. Roodnat, (unknown), Willem Weimar, Dennis A. Hesselink, Teun van Gelder	110
7	Pretransplant Tacrolimus Dose Requirements Predict Early Posttransplant Dose Requirements in Blood Group AB0-Incompatible Kidney Transplant Recipients 2015 ·Therapeutic Drug Monitoring ·Nauras Shuker, Femke M. de Man, Annelies E. de Weerd, Madelon van Agteren, Willem Weimar, Michiel G.H. Betjes, Teun van Gelder, Dennis A. Hesselink	2
8	A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype‐Based With Body‐Weight‐Based Tacrolimus Dosing After Living Donor Kidney Transplantation 2015 ·American Journal of Transplantation ·Nauras Shuker, Rachida Bouamar, Ron H. N. van Schaik, Marian C. Clahsen‐van Groningen, Jeffrey Damman, Carla C. Baan, Jacqueline van de Wetering, Ajda T. Rowshani, W. Weimar, Teun van Gelder, Dennis A. Hesselink	128
9	Conversion to Once-Daily Tacrolimus Results in Increased p38MAPK Phosphorylation in T Lymphocytes of Kidney Transplant Recipients 2015 ·Therapeutic Drug Monitoring ·(unknown), Nauras Shuker, (unknown), Willem Weimar, Dennis A. Hesselink, Carla C. Baan	5
10	Intra-patient variability in tacrolimus exposure: Causes, consequences for clinical management 2015 ·Transplantation Reviews ·Nauras Shuker, Teun van Gelder, Dennis A. Hesselink	171
11	Conversion From the Twice-Daily to the Once-Daily Tacrolimus Formulation Does Not Reduce Intra-Patient Variability in Tacrolimus Exposure. 2014 ·Transplantation ·Nauras Shuker, Teun van Gelder, (unknown), Wendi H. Weimar, Dennis A. Hesselink	1
12	Conversion From Twice-Daily to Once-Daily Tacrolimus Does Not Reduce Intrapatient Variability in Tacrolimus Exposure 2014 ·Therapeutic Drug Monitoring ·Nauras Shuker, (unknown), Teun van Gelder, Joke I. Roodnat, Marcia M. L. Kho, Willem Weimar, Dennis A. Hesselink	22
13	Do Asian renal transplant patients need another mycophenolate mofetil dose compared with Caucasian or African American patients? 2014 ·Transplant International ·Pengmei Li, Nauras Shuker, Dennis A. Hesselink, Ron H. N. van Schaik, Xianglin Zhang, Teun van Gelder	30
14	Tacrolimus Predose Concentrations Do Not Predict the Risk of Acute Rejection After Renal Transplantation: A Pooled Analysis From Three Randomized-Controlled Clinical Trials 2013 ·American Journal of Transplantation ·Rachida Bouamar, Nauras Shuker, Dennis A. Hesselink, Willem Weimar, Henrik Ekberg, Bruce Kaplan, Corrado Bernasconi, Teun van Gelder	125
15	Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocks 2013 ·British Journal of Clinical Pharmacology ·Laure Elens, Rachida Bouamar, Nauras Shuker, Dennis A. Hesselink, Teun van Gelder, Ron H. N. van Schaik	34
16	ATP-binding cassette transporters as pharmacogenetic biomarkers for kidney transplantation 2011 ·Clinica Chimica Acta ·Nauras Shuker, Rachida Bouamar, Willem Weimar, Ron H. N. van Schaik, Teun van Gelder, Dennis A. Hesselink	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact